Featured News

Anokion SA announced successful completion of its Phase 1 clinical trial evaluating KAN-101 for the treatment of celiac disease, with promising results.

I want to share with you an update of our work in Washington, DC with Congress and NIH to accelerate research for diagnostics, treatments, and a cure for celiac disease.

Thanks to your generous support, we are deploying iCureCeliac and iQualifyCeliac, as well as other assets unique to the Foundation, to further celiac disease drug development.

CDF has been approved for a $100,000 funding award through the Eugene Washington PCORI Engagement Awards program. The funds will support the community convening of patient advocates, researchers, and other key stakeholders to create a roadmap for patient advocate engagement in research.

The Celiac Disease Foundation, the nation’s leading disease advocacy organization for celiac disease, announces the appointment of officers to its Board of Directors.

For decades, the celiac disease community has been told that the pain, the suffering, the fog, the depression, and the missed days of work and school were our fault because we failed to adhere to the diet—or in the case of a parent or caregiver, failed to enforce strict adherence by a child or loved…

The first annual Team Gluten-Free Turkey Trot in Oyster Bay, NY drew 125 participants and raised nearly $25,000! A picture perfect day on the beach greeted our families, who were welcomed by tables filled with gluten-free food and Team Gluten-Free swag. This year’s participants ranged from age four through 85, with our youngest medal winner…

Having a child with celiac disease poses unique challenges both for you and your child. The lifestyle changes – and how they are managed – that come with a diagnosis of celiac disease can be difficult during the school-age years. Celiac Disease Foundation has developed this Back-to-School and 504 Plan Guide to help you and your…

For 25 years, Celiac Disease Foundation has helped families struggling with celiac disease. Watch this special message from father and daughter Board Members Marvin and Deidre Berman.

Celimmune, in partnership with the University of Chicago Celiac Disease Center, and Celiac Disease Foundation have joined forces to deploy the iCureCeliac patient registry as a screen for phase 2 clinical study for refractory celiac disease type II. This is the first-ever use of the new and growing iCureCeliac registry to support celiac disease therapeutic treatment…